Vietnam | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2011 - 2022
The value of exports of commodity group 30 "Pharmaceutical products" from Vietnam totalled $ 261 million in 2022. Sales of commodity group 30 from Vietnam went up by 50% compared to 2021: exports of commodity group 30 "Pharmaceutical products" went up by $ 87 million (cumulative exports of commodity group 30 from Vietnam amounted $174 million in 2021)
Exports of commodity group 30 "Pharmaceutical products" amounted to 0.07% of total exports from Vietnam (cumulative merchandise exports from Vietnam totalled $ 370 billion in 2022). The share of commodity group 30 in total exports from Vietnam increased by 0.018 p.p. compared to 2021 (it was 0.051% in 2021 and cumulative exports from Vietnam were equal to $ 335 billion).
Where does Vietnam export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Vietnam in 2022:
- Japan with a share of 18% (47 million US$)
- Cyprus with a share of 11.9% (31 million US$)
- Philippines with a share of 9.26% (24 million US$)
- Cambodia with a share of 8.87% (23 million US$)
- Germany with a share of 5.95% (15.5 million US$)
- USA with a share of 5.67% (14.8 million US$)
- Korea with a share of 5.23% (13.6 million US$)
- Myanmar with a share of 4.36% (11.3 million US$)
- Malaysia with a share of 3.1% (8.11 million US$)
- China with a share of 3.08% (8.04 million US$)
Exports structure of 30 - Pharmaceutical products - from Vietnam in 2022 represented by the following main commodity groups:
- 79% (207 million US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 7.16% (18.7 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 5.53% (14.4 million US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 5.02% (13.1 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 1.66% (4.34 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 1.37% (3.59 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
The value of imports of commodity group 30 "Pharmaceutical products" to Vietnam totalled $ 3.78 billion in 2022. Sales of commodity group 30 to Vietnam decreased by 10.6% in value terms compared to 2021. imports of commodity group 30 "Pharmaceutical products" decreased by $ 452 million (the value of imports of commodity group 30 to Vietnam was equal to $4.23 billion in 2021)
Imports of commodity group 30 "Pharmaceutical products" accounted for 1.05% of total import flow to Vietnam (in 2022, total imports to Vietnam amounted to $ 358 billion). The share of commodity group 30 in total imports to Vietnam decreased by 0.226 p.p. compared to 2021 (it was 1.28% in 2021 and cumulative imports to Vietnam were equal to $ 330 billion).
Where does Vietnam import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Vietnam in 2022:
- USA with a share of 12% (457 million US$)
- France with a share of 11.7% (443 million US$)
- Germany with a share of 9.88% (374 million US$)
- India with a share of 7.99% (302 million US$)
- Belgium with a share of 7.67% (290 million US$)
- Korea with a share of 6.42% (243 million US$)
- Italy with a share of 4.65% (176 million US$)
- Thailand with a share of 3.29% (124 million US$)
- Ireland with a share of 2.51% (95 million US$)
- Spain with a share of 2.5% (94 million US$)
Imports structure of 30 - Pharmaceutical products - to Vietnam in 2022 represented by the following main commodity groups:
- 65% (2.46 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 30% (1.13 billion US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 2.07% (78 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 1.68% (63 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.92% (34 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.212% (8.03 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
